Losartan Potassium
- Product NDC
- 62207-742
- 11-digit product format
- 622070742
- Labeler code
- 62207
- Product ID
- 62207-742_39e0a359-f9d7-c3fb-e063-6394a90a86a8
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Losartan
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Granules India Ltd
- Application
- ANDA215959
- Marketing category
- ANDA
- Marketing start
- 2023-03-08
- Substance
- LOSARTAN POTASSIUM
- Active strength
- 50 mg/1
- Pharmacologic classes
- Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Losartan Potassium
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| LOSARTAN POTASSIUM | 50 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 3ST302B24A |
| Rxcui | 979480, 979485, 979492 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 62207-742-49 | Losartan Potassium | 1000 in 1 BOTTLE | TABLET | 1000 | | 2 |
| 62207-742-54 | Losartan Potassium | 30 in 1 BOTTLE | TABLET | 30 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 62207-742 | LOSARTAN POTASSIUM (LOSARTAN) TABLET [GRANULES INDIA LTD] | 1 | Current NDC, 2 package rows | 20250319_f9953f51-f30a-952d-e053-6394a90abf5f.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 62207-742-49 | 62207074249 | 1000 TABLET in 1 BOTTLE (62207-742-49) | 1000 tablet | 2025-03-18 | No | No | Current |
| 62207-742-54 | 62207074254 | 30 TABLET in 1 BOTTLE (62207-742-54) | 30 tablet | 2025-03-18 | No | No | Current |